v3.26.1
Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total Metropolitan Life Insurance Company Stockholder’s Equity
Noncontrolling Interests
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Total Metropolitan Life Insurance Company Stockholder’s Equity
Beginning Balance at Dec. 31, 2024 $ 14,434 $ 5 $ 12,475 $ 7,444 $ (5,994) $ 13,930 $ 504 $ (1,074) $ (1,074) $ (1,074)
Dividends to MetLife, Inc. (1,365)     (1,365)   (1,365)        
Change in equity of noncontrolling interests (44)         0 (44)      
Net income (loss) 335     337   337 (2)      
Other comprehensive income (loss), net of income tax 1,126       1,126 1,126        
Ending Balance at Mar. 31, 2025 13,412 5 12,475 6,416 (5,942) 12,954 458      
Beginning Balance at Dec. 31, 2025 14,535 5 12,475 6,677 (5,236) 13,921 614      
Dividends to MetLife, Inc. (1,309)     (1,309)   (1,309)        
Change in equity of noncontrolling interests 57         0 57      
Net income (loss) 856     860   860 (4)      
Other comprehensive income (loss), net of income tax (328)       (328) (328)        
Ending Balance at Mar. 31, 2026 $ 13,811 $ 5 $ 12,475 $ 6,228 $ (5,564) $ 13,144 $ 667